The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions For Improving Cell Viability And Methods Of Use Thereof

Patent No. EP2978419 (titled "Compositions For Improving Cell Viability And Methods Of Use Thereof") was filed by Amylyx Pharmaceuticals on Feb 24, 2014. The application was issued on Apr 15, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBJan 12, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
BRUSCHETTINIJan 11, 2021PISTOLESI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2978419

AMYLYX PHARMACEUTICALS
Application Number
EP14775675A
Filing Date
Feb 24, 2014
Status
Opposition Rejected
Oct 21, 2022
Publication Date
Apr 15, 2020
External Links
Slate, EP2978419B1, Google Patents